BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12097435)

  • 1. Salivary defense factors in herpes simplex virus infection.
    Välimaa H; Waris M; Hukkanen V; Blankenvoorde MF; Nieuw Amerongen AV; Tenovuo J
    J Dent Res; 2002 Jun; 81(6):416-21. PubMed ID: 12097435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris.
    Kurata M; Mizukawa Y; Aoyama Y; Shiohara T
    Br J Dermatol; 2014 Sep; 171(3):554-60. PubMed ID: 24660994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients.
    da Silva LM; Guimarães AL; Victória JM; Gomes CC; Gomez RS
    Oral Dis; 2005 Jan; 11(1):13-6. PubMed ID: 15641961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic Reactivation of HSV Infection Correlates with Decreased Serum Levels of TNF-α.
    Motamedifar M; Sarvari J; Ebrahimpour A; Emami A
    Iran J Immunol; 2015 Mar; 12(1):27-34. PubMed ID: 25784095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intimate male partner violence impairs immune control over herpes simplex virus type 1 in physically and psychologically abused women.
    Garcia-Linares MI; Sanchez-Lorente S; Coe CL; Martinez M
    Psychosom Med; 2004; 66(6):965-72. PubMed ID: 15564366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assay method for herpes simplex virus type 1 seroprevalence survey--detection of antibody in saliva by avidin-biotin complex enzyme-linked immunosorbent assay (ABC-ELISA).
    Zhang ZQ
    Microbiol Immunol; 1993; 37(10):773-7. PubMed ID: 8289684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-1 DNA in tears and saliva of normal adults.
    Kaufman HE; Azcuy AM; Varnell ED; Sloop GD; Thompson HW; Hill JM
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):241-7. PubMed ID: 15623779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary neutralizing activity against herpes simplex virus type 1.
    Gyselink R; Coles D; Ash RJ; Fritz ME
    J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of immune control over herpes simplex virus type 1 in female victims of intimate partner violence.
    Sanchez-Lorente S; Blasco-Ros C; Coe CL; Martinez M
    Psychosom Med; 2010 Jan; 72(1):97-106. PubMed ID: 19933506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of HSV-1 IgG antibodies by two methods comparing in Turkish atopic children.
    Artiran Igde F; Igde M; Yazici Z; Okur Gumusova S; Birinci A; Sancak R; Ozturk F
    New Microbiol; 2007 Apr; 30(2):109-12. PubMed ID: 17619253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of dental surgery on HSV-1 reactivation in the oral mucosa of seropositive patients.
    Marques-Silva L; Castro WH; Gomez EL; Guimarães AL; Silva MS; Gomez RS
    J Oral Maxillofac Surg; 2007 Nov; 65(11):2269-72. PubMed ID: 17954324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
    McKenna DB; Neill WA; Norval M
    Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of several ELISA tests for detecting the presence of IgG and IgM against herpes simplex viruses.
    Gutiérrez J; Fernández F; Vergara MJ; Suárez S; Soto MJ; Maroto MC
    Microbios; 2000; 103(405):127-32. PubMed ID: 11092194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
    Morrow R; Friedrich D
    Clin Microbiol Infect; 2006 May; 12(5):463-9. PubMed ID: 16643524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis.
    Brice SL; Stockert SS; Bunker JD; Bloomfield D; Huff JC; Norris DA; Weston WL
    Arch Dermatol Res; 1993; 285(4):193-6. PubMed ID: 8342962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between herpes simplex virus-1 infection and idiopathic unilateral facial paralysis in children and adolescents.
    Khine H; Mayers M; Avner JR; Fox A; Herold B; Goldman DL
    Pediatr Infect Dis J; 2008 May; 27(5):468-9. PubMed ID: 18360300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.
    Pica F; Volpi A; Gaziano R; Garaci E
    Antivir Ther; 2010; 15(5):737-43. PubMed ID: 20710055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
    Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
    Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.